Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.65B |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$6.34B |
| 3 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.28B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.36B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.04B |
Top Sells
| 1 |
Texas Instruments
TXN
|
+$387M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$272M |
| 4 |
Medtronic
MDT
|
+$249M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| 1 | Technology | 21.37% |
| 2 | Financials | 10.65% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Lyell Immunopharma
LYEL
$253M
| $1.88M | ﹤0.01% |
64,882
+911
| +1% | +$26.4K |
|
2727
Nektar Therapeutics
NKTR
$886M
| $1.84M | ﹤0.01% |
99,182
+23,961
| +32% | +$446K |
|
2728
Target Hospitality
TH
$875M
| $1.84M | ﹤0.01% |
211,021
-20,945
| -9% | -$182K |
|
2729
ZTO Express
ZTO
$15.4B
| $1.83M | ﹤0.01% |
+88,237
| New | +$1.83M |
|
2730
Universal Technical Institute
UTI
$1.51B
| $1.83M | ﹤0.01% |
116,034
+4,963
| +4% | +$78.1K |
|
2731
Allient
ALNT
$787M
| $1.82M | ﹤0.01% |
71,927
+6,518
| +10% | +$165K |
|
2732
RLX Technology
RLX
$3.25B
| $1.81M | ﹤0.01% |
986,306
-8,260
| -0.8% | -$15.2K |
|
2733
Stratasys
SSYS
$846M
| $1.81M | ﹤0.01% |
215,599
-63,626
| -23% | -$534K |
|
2734
TTEC Holdings
TTEC
$179M
| $1.81M | ﹤0.01% |
307,315
-23,059
| -7% | -$136K |
|
2735
Johnson Outdoors
JOUT
$423M
| $1.79M | ﹤0.01% |
51,243
+2,662
| +5% | +$93.1K |
|
2736
Granite Ridge Resources
GRNT
$701M
| $1.79M | ﹤0.01% |
282,959
+42,035
| +17% | +$266K |
|
2737
Liberty Latin America Class A
LILA
$1.52B
| $1.79M | ﹤0.01% |
186,251
-131,282
| -41% | -$1.26M |
|
|
THRD
2738
DELISTED
Third Harmonic Bio
THRD
| $1.79M | ﹤0.01% |
137,462
+6,857
| +5% | +$89.1K |
|
2739
Harrow
HROW
$1.48B
| $1.78M | ﹤0.01% |
85,027
+3,198
| +4% | +$66.8K |
|
2740
Metals Acquisition
MTAL
$1.01B
| $1.78M | ﹤0.01% |
+129,738
| New | +$1.78M |
|
2741
Dianthus Therapeutics
DNTH
$1.18B
| $1.77M | ﹤0.01% |
+68,567
| New | +$1.77M |
|
2742
Telos
TLS
$504M
| $1.77M | ﹤0.01% |
440,945
+162,059
| +58% | +$651K |
|
2743
Miller Industries
MLR
$469M
| $1.74M | ﹤0.01% |
31,708
+1,414
| +5% | +$77.8K |
|
|
FLIC
2744
DELISTED
First of Long Island Corp
FLIC
| $1.73M | ﹤0.01% |
172,968
+3,735
| +2% | +$37.4K |
|
2745
Precigen
PGEN
$1.23B
| $1.73M | ﹤0.01% |
1,095,383
+26,856
| +3% | +$42.4K |
|
2746
IMAX
IMAX
$1.7B
| $1.73M | ﹤0.01% |
103,201
-21,473
| -17% | -$360K |
|
2747
Microvision
MVIS
$349M
| $1.73M | ﹤0.01% |
1,631,875
+242,835
| +17% | +$257K |
|
|
TSVT
2748
DELISTED
2seventy bio
TSVT
| $1.73M | ﹤0.01% |
449,278
-165,247
| -27% | -$636K |
|
2749
Solid Power
SLDP
$676M
| $1.73M | ﹤0.01% |
1,048,084
+77,705
| +8% | +$128K |
|
2750
Kiniksa Pharmaceuticals
KNSA
$2.72B
| $1.73M | ﹤0.01% |
92,408
+8,253
| +10% | +$154K |
|